Cargando…
New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of tumours, and its incidence is rising worldwide. Although survival can be improved by surgical resection when these tumours are detected at an early stage, this cancer is usually asymptomatic, and disease only becomes apparent...
Autores principales: | Garcia-Carbonero, Nuria, Li, Weiyao, Cabeza-Morales, Marticela, Martinez-Useros, Javier, Garcia-Foncillas, Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165247/ https://www.ncbi.nlm.nih.gov/pubmed/30134550 http://dx.doi.org/10.3390/ijms19092468 |
Ejemplares similares
-
Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment
por: Martinez-Useros, Javier, et al.
Publicado: (2017) -
Iron-Dependent Cell Death: A New Treatment Approach against Pancreatic Ductal Adenocarcinoma
por: Lopez-Blazquez, Carlos, et al.
Publicado: (2023) -
The Prognosis Value of PIWIL1 and PIWIL2 Expression in Pancreatic Cancer
por: Li, Weiyao, et al.
Publicado: (2019) -
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept
por: Martinez-Useros, Javier, et al.
Publicado: (2017) -
KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study
por: Garcia-Carbonero, Nuria, et al.
Publicado: (2020)